Literature DB >> 947499

Recovery of ventilatory response to carbon dioxide after thiopentone, morphine and fentanyl in man.

J R Rigg, C H Goldsmith.   

Abstract

Ventilatory responses to CO2 (delta VI/delta PCO2) were measured half, one, two and four hours after infusions of thiopentone, morphine, fentanyl and saline in healthy men in order to test the idea that variation in clinical recovery and control of breathing after anaesthetic drugs are associated with interindividual differences in control measurements of delta VI/delta PCO2. Ventilatory response to CO2 was profoundly reduced one half hour after each drug, in contrast to the observation during air breathing that ventilation and end tidal PCO2 had returned to within 10 per cent of control. Mean delta VI/delta PCO2 increased progressively at one, two, and four hours, returning to near control after thiopentone, but remaining less than 80 per cent of control four hours after morphine and fentanyl. From the regression equations of each ventilatory response, ventilation at PCO2 of 58 and 70 mmHg (VI58 and VI70) were computed to estimate displacement of the response curves by the drugs. Following thiopentone there was no significant change of V158. In contrast ther was a highly siginificant fall of VI58 one half hour after fentanyl (p less than 0.01), with progressive return towards control at one, two, and four hours; similar changes were observed after morphine. For each drug, changes of VI70 were substantially greater than corresponding changes of V158. At all times during these recovery measurements, subjects were conscious and co-operative and, by traditional clinical criteria, were judged to have recovered from the effects of the drugs. Differences between high and low responding subjects were assessed by plotting control measurements against values obtained half and one hour after drugs. No systematic differences were found. These findings suggest that delta VI/delta PCO2 is a sensitive indicator of central nervous activity, but do not support the concepts that individuals with low delta VI/delta PCO2 might be more susceptible to the ventilatory depressant effects of anaesthetic drugs, or that low delta VI/delta PCO2 might be associated with delayed return of spontaneous breathing after general anaesthesia. Plasma thiopentone levels at half, one, and four hours were highly reproducible, in contrast to the wide variation of delta VI/delta PCO2 among subjects in this study. These findings together support the notion that wide variation in clinical recovery from anaesthesia may have a primary physiological basis in addition to variation caused by interindividual differences in drug dosage, biotransformation and excretion.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 947499     DOI: 10.1007/bf03005917

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  17 in total

1.  The effect of intravenous infusion of noradrenaline on the respiratory response to carbon dioxide in man.

Authors:  D J CUNNINGHAM; E N HEY; B B LLOYD
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1958-10

2.  Respiratory responses to carbon dioxide transients during ether and cyclopropane anesthesia.

Authors:  S COBB; J G CONVERSE; C M LANDMESSER
Journal:  Anesthesiology       Date:  1958 May-Jun       Impact factor: 7.892

3.  Effect of posture on the ventilatory response to CO2.

Authors:  J R Rigg; A S Rebuck; E J Campbell
Journal:  J Appl Physiol       Date:  1974-10       Impact factor: 3.531

4.  The effects of halothane, fluroxene and cyclopropane on ventilation: a comparative study in man.

Authors:  E S Munson; C P Larson; A A Babad; M J Regan; D R Buechel; E I Eger
Journal:  Anesthesiology       Date:  1966 Nov-Dec       Impact factor: 7.892

5.  A double-blind controlled study of the effects on respiration of pentazocine, phenoperidine and morphine in normal man.

Authors:  S Jennett; J G Barker; J B Forrest
Journal:  Br J Anaesth       Date:  1968-11       Impact factor: 9.166

6.  On the regulation of depth and rate of breathing.

Authors:  F J Clark; C von Euler
Journal:  J Physiol       Date:  1972-04       Impact factor: 5.182

7.  Relationship between sensitivity to carbon dioxide and clinical features in patients with chronic airways obstruction.

Authors:  D J Lane; J B Howell
Journal:  Thorax       Date:  1970-03       Impact factor: 9.139

8.  The enhancement of neurological signs under anaesthesia. Case reports.

Authors:  A E Edwards; J F Bras
Journal:  Br J Anaesth       Date:  1970-04       Impact factor: 9.166

9.  The effects of diethyl ether and methoxyflurane on ventilation: II. A comparative study in man.

Authors:  C P Larson; E I Eger; M Muallem; D R Buechel; E S Munson; J H Eisele
Journal:  Anesthesiology       Date:  1969-02       Impact factor: 7.892

10.  The relationship between binding of thiopental to plasma and its distribution into adipose tissue in man, as measured by a spectrophotofluorometric method.

Authors:  P G Dayton; J M Perel; M A Landrau; L Brand; L C Mark
Journal:  Biochem Pharmacol       Date:  1967-12       Impact factor: 5.858

View more
  6 in total

1.  Delayed respiratory depression with fentanyl.

Authors:  J Smydo
Journal:  Anesth Prog       Date:  1979 Mar-Apr

2.  Delayed respiratory depression after use of fentanyl during anaesthesia.

Authors:  A P Adams; D A Pybus
Journal:  Br Med J       Date:  1978-02-04

Review 3.  Pulmonary atelectasis after anaesthesia: pathophysiology and management.

Authors:  J R Rigg
Journal:  Can Anaesth Soc J       Date:  1981-07

Review 4.  A comprehensive review of rapid-onset opioids for breakthrough pain.

Authors:  Howard Smith
Journal:  CNS Drugs       Date:  2012-06-01       Impact factor: 5.749

5.  Fentanyl, rather than Tramadol: A cause of respiratory depression.

Authors:  Ghansham Biyani; Sadik Mohammed; Pradeep Bhatia
Journal:  Indian J Anaesth       Date:  2012-01

6.  Considerations in selecting rapid-onset opioids for the management of breakthrough pain.

Authors:  Howard S Smith
Journal:  J Pain Res       Date:  2013-03-06       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.